Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice

Clinical and Vaccine Immunology

Volumn 19, Issue 12, 2012, Pages 1916-1920

  Wang, Pei Yuan ^a,b   Yuan, Zi Guo ^a,b   Petersen, Eskild ^c   Li, Jie ^a,b   Zhang, Xiu Xiang ^b   Li, Xiu Zhen ^b   Li, Hao Xin ^b   Lv, Zhi Cheng ^b   Cheng, Tian ^b   Ren, Di ^b   Yang, Gui Lian ^d   Lin, Rui Qing ^b   Zhu, Xing Quan ^a,e,f  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^c AARHUS UNIVERSITY   (Denmark)

^d JILIN AGRICULTURAL UNIVERSITY   (China)

^e YUNNAN AGRICULTURAL UNIVERSITY   (China)

^f HEILONGJIANG BAYI AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; RHOPTRY PROTEIN 13 PLASMID DNA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SAFETY; EXPRESSION VECTOR; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SURVIVAL TIME; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; BRAIN; CELL PROLIFERATION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; GENETIC VECTORS; INJECTIONS, INTRAMUSCULAR; LEUKOCYTES, MONONUCLEAR; MICE; PARASITE LOAD; PLASMIDS; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; TOXOPLASMA; TOXOPLASMOSIS; VACCINES, DNA; VIRULENCE FACTORS;

EID: 84870416477     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00397-12     Document Type: Article

References (27)

1. Bradley PJ, et al. 2005. Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii. J. Biol. Chem. 280:34245-34248.
2. Di Cristina M, et al. 2004. The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection. Microbes Infect. 6:164-171. (Pubitemid 38293293)
3. Dubey JP. 2010. Toxoplasmosis of animals and humans, 2nd ed. CRC Press Inc., Boca Raton, FL.
4. Hyodo Y, et al. 1999. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J. Immunol. 162:1662-1668. (Pubitemid 29307043)
5. Innes EA, Vermeulen AN. 2006. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 133(Suppl.):S145-S168. (Pubitemid 46208035)
6. Jongert E, et al. 2008. An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Vaccine 26:1025-1031.
7. Kur J, Holec-Gasior L, Hiszczyńska-Sawicka E. 2009. Current status of toxoplasmosis vaccine development. Expert Rev. Vaccines 8:791-808.
8. Liu MM, et al. 2010. Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitol. Res. 106:1079-1084.
9. Liu Q, et al. 2010. The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18. Res. Vet. Sci. 89:93-97.
10. Lourenco EV, et al. 2006. Immunization with MIC1 and MIC4 induces protective immunity against Toxoplasma gondii. Microbes Infect. 8:1244-1251. (Pubitemid 43831688)
11. Marshall DJ, et al. 2006. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine. Vaccine 24:244-253. (Pubitemid 41790427)
12. Mastroeni P, et al. 1999. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect. Immun. 67:478-483. (Pubitemid 29059176)
13. Mateus-Pinilla NE, Dubey JP, Choromanski L, Weigel RM. 1999. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. J. Parasitol. 85:855-860. (Pubitemid 29506293)
14. Mishima M, et al. 2002. Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in cats. Parasitol. Res. 88:144-149. (Pubitemid 34151142)
15. Montoya JG, Liesenfeld O. 2004. Toxoplasmosis. Lancet 363:1965-1976. (Pubitemid 38759657)
16. Okamura H, et al. 1995. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect. Immun. 63:3966-3972.
17. Okamura H, et al. 1995. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88-91.
18. Peng GH, et al. 2009. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice. Vaccine 27:6570-6574.
19. Salagianni M, Wong KL, Thomas MJ, Noble A, Kemeny DM. 2007. An essential role for IL-18 in CD8 T cell-mediated suppression of IgE responses. J. Immunol. 178:4771-4778. (Pubitemid 46595258)
20. Tenter AM, Heckeroth AR, Weiss LM. 2000. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30:1217-1258.
21. Turetzky JM, Chu DK, Hajagos BE, Bradley PJ. 2010. Processing and secretion of ROP13: a unique Toxoplasma effector protein. Int. J. Parasitol. 40:1037-1044.
22. Wang H, et al. 2007. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitol. Int. 56:263-268. (Pubitemid 47391413)
23. Wei F, et al. 2008. Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26 kDa GST plasmid DNA vaccine in mice. Vaccine 26:4145-4149.
24. Wei XQ, et al. 1999. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J. Immunol. 163:2821-2828.
25. Yuan ZG, et al. 2011. Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice. Clin. Vaccine Immunol. 18:119-124.
26. Yuan ZG, et al. 2011. Protective effect against toxoplasmosis in mice induced by DNA immunization with gene encoding Toxoplasma gondii ROP18. Vaccine 29:6614-6619.
27. Zhang T, et al. 1997. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. Immun. 65:3594-3599. (Pubitemid 27398112)